Compound Detail
CHEMBL5864617
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
O=C(NCc1ccc(Cl)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)[C@H]1C2
Basic Information
| ChEMBL ID | CHEMBL5864617 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CLDKIKVUKMVPFT-AKWBHNSASA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
431.9
MW (Da)
2.28
ALogP
5
HBA
2
HBD
91.6
PSA (Ų)
0.78
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.38
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Solute carrier family 22 member 2 CHEMBL1743122 | IC50 | 7.38 | 7.38 | 42.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Solute carrier family 22 member 2 | IC50 | = | 42.0 | nM | 7.38 | Inhibition Assay: The dose dependent inhibition of OCT2 mediated uptake of a mod... | - |
Data from ChEMBL 36 via Core Engine